Jens C. Schwamborn
Belvaux, ES, Luxembourg
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 132 publications
Brain organoids in Parkinson's disease drug development: Human-specific models for translational discovery.
Journal: Drug discovery today
Published: April 16, 2026
Subthreshold membrane depolarization powerfully engages intracellular calcium dynamics in the brain.
Subthreshold membrane depolarization powerfully engages intracellular calcium dynamics in the brain.
Journal: bioRxiv : the preprint server for biology
Published: March 16, 2026
LRRK2 Mutation Alters Dopamine D2 Receptor Localization in Induced Pluripotent Stem Cells-Derived Astrocytes From Parkinson's Disease Patients: Implications for Neuronal Damage.
Journal: Journal of neurochemistry
Published: December 16, 2025
SARS-CoV-2 Infection Induces Dopaminergic Neuronal Loss in Midbrain Organoids.
Journal: Journal of neurochemistry
Published: November 06, 2025
Autophagy dysfunction in iPSCs-derived neurons and midbrain organoids carrying a SNCA triplication.
Journal: NPJ Parkinson's disease
Published: August 08, 2025
Investigating the ageing-Parkinson's disease nexus: standardisation of in vitro models and techniques by the PD-AGE network.
Journal: NPJ Parkinson's disease
Published: June 26, 2025
Parkinson's Disease Patient-Specific Striatum Organoids Show Hallmarks of Increased Inflammation.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: June 19, 2025
Reproducibility of PD patient-specific midbrain organoid data for in vitro disease modeling.
Journal: iScience
Published: May 16, 2025
Functional recovery through the plastic adaptation of organoid grafts in cortical tissue.
Journal: Cellular and molecular life sciences : CMLS
Published: February 02, 2025
Single-cell analysis reveals shared and distinct molecular signatures in brain organoid models of neurodegeneration and neuroinflammation.
Journal: Alzheimer's research & therapy
Published: January 27, 2025
The Parkinson's disease-associated LRRK2-G2019S variant restricts serine metabolism, leading to microglial inflammation and dopaminergic neuron degeneration.
Journal: Journal of neuroinflammation
Published: January 02, 2025
Last Updated: 09/26/2026